Bibliographic information
Recommendation
For patients with severe or critical COVID-19. The WHO recommends not to use convalescent plasma for treatment of COVID-19, except in the context of a clinical trial
Recommended against
Strong
Certainty of evidence
Low
Also Featured In
This recommendation also appears in the following guidelines:
Therapeutics and COVID-19. Living guideline. 7 December 2021
Therapeutics and COVID-19: living guideline, 14 January 2022.
Therapeutics and COVID-19: living guideline, 3 March 2022.
Therapeutics and COVID-19: living guideline, 22 April 2022.
Therapeutics and COVID-19: living guideline, 14 July 2022.
Therapeutics and COVID-19: living guideline, 13 January 2023.
Therapeutics and COVID-19: living guideline, 10 November 2023.
Therapeutics and COVID-19: living guideline, August 2025